Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank M. Sands currently holds 13,018,965 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank M. Sands has been a net buyer of ABOS stock. They have purchased $9.7M and sold $0 worth of shares.
Frank M. Sands's most recent insider trade was on Nov 21, 2025, when they purchased 2,068,965 shares at $1.45 per share.
Frank M. Sands serves as Executive at Acumen Pharmaceuticals, Inc. (ABOS). They have executed 4 insider transactions totaling $9.7M over their tenure at the company.
Frank M. Sands holds the position of Executive at Acumen Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Frank M. Sands has shown a buying trading pattern, with $9.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Frank M. Sands was on Jul 6, 2021, when they purchased $6.7M worth of ABOS shares. This transaction involved 450,000 shares at $14.88 per share.
Frank M. Sands currently owns 13,018,965 shares of Acumen Pharmaceuticals, Inc. (ABOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank M. Sands's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank M. Sands has 4 Form 4 filings on record as an insider at Acumen Pharmaceuticals, Inc..
Set alerts for Frank M. Sands and 40,000+ other insiders.